Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Radiofrequency Ablation of Inoperable Non-Small Cell Lung Cancer

Radiofrequency Ablation of Inoperable Non-Small Cell Lung Cancer PISA SYMPOSIUM Radiofrequency Ablation of Inoperable Non-Small Cell Lung Cancer Marcello Carlo Ambrogi, MD, Paolo Dini, MD, Franca Melfi, MD, and Alfredo Mussi, MD (J Thorac Oncol. 2007;2: Suppl 1, 2–3) the administration of contrast material before and after coag- ulation to obtain information about the real effectiveness of the procedure. In a selected group of patients with the tumor adio frequency ablation (RFA) of lung tumors is a rela- in contact with the thoracic wall, it is possible to work under Rtively new procedure allowing local treatment with min- ultrasound guidance. The needle electrode is inserted through imal parenchymal damage. This technique is able to induce an intercostal space after administration of local anesthesia. coagulative necrosis in a limited pulmonary area. This emerg- The correct placement is confirmed by CT or ultrasound ing technology is used to achieve local treatment of primary and before applying the radiofrequency energy. The target tem- secondary lung tumors in patients with poor clinical status or perature of ablation is 90°C. It is maintained for 15 to 27 2,3 technical contraindications to surgical resection. minutes according to the size of the tumor; this variable also determines the gradual deployment of the electrodes, starting http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Radiofrequency Ablation of Inoperable Non-Small Cell Lung Cancer

Journal of Thoracic Oncology , Volume 2 – May 1, 2007

Loading next page...
 
/lp/wolters-kluwer-health/radiofrequency-ablation-of-inoperable-non-small-cell-lung-cancer-mYLKwTEq0X

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

PISA SYMPOSIUM Radiofrequency Ablation of Inoperable Non-Small Cell Lung Cancer Marcello Carlo Ambrogi, MD, Paolo Dini, MD, Franca Melfi, MD, and Alfredo Mussi, MD (J Thorac Oncol. 2007;2: Suppl 1, 2–3) the administration of contrast material before and after coag- ulation to obtain information about the real effectiveness of the procedure. In a selected group of patients with the tumor adio frequency ablation (RFA) of lung tumors is a rela- in contact with the thoracic wall, it is possible to work under Rtively new procedure allowing local treatment with min- ultrasound guidance. The needle electrode is inserted through imal parenchymal damage. This technique is able to induce an intercostal space after administration of local anesthesia. coagulative necrosis in a limited pulmonary area. This emerg- The correct placement is confirmed by CT or ultrasound ing technology is used to achieve local treatment of primary and before applying the radiofrequency energy. The target tem- secondary lung tumors in patients with poor clinical status or perature of ablation is 90°C. It is maintained for 15 to 27 2,3 technical contraindications to surgical resection. minutes according to the size of the tumor; this variable also determines the gradual deployment of the electrodes, starting

Journal

Journal of Thoracic OncologyWolters Kluwer Health

Published: May 1, 2007

There are no references for this article.